Browsing: Longevity

Altimmune raises $75 million to advance pemvidutide, a promising therapy tackling serious liver and metabolic diseases. For most, liver disease…

PMD trial ties functional measures with NAD⁺ and redox biomarkers, offering a pragmatic view of mitochondrial modulation. Primary mitochondrial disease…

Corsera COO explains why the biotech is building an AI-powered risk assessment tool alongside RNAi therapies targeting CVD. Earlier this…

Correcting for extrinsic mortality suggests intrinsic lifespan is far more heritable than previously thought. For decades, the heritability of human…

Funding to support commercial launch and continued development of treatments designed to ‘rejuvenate vision in the aging eye.’ British-American biotech…

Personalized nutrition pioneer brings 3D-printed gummies and live demos to London as longevity moves from theory to everyday practice. Rem3dy…

New membership-based service at Raffles Hotel Arcade blends medical oversight, AI-supported research and high-touch coordination. Singapore’s increasingly crowded longevity and…

Tiny wireless chips injected through the bloodstream could reshape how we treat brain disease and how long we stay well.…

New research identifies a regulator that helps the brain use amyloid assembly in a controlled way – with implications for…

New study shows APOE genetics may explain up to 90% of Alzheimer’s risk, which may help in reshaping prevention strategies.…